Delphia (USA)’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-14,630
Closed -$39K 410
2022
Q1
$39K Buy
+14,630
New +$39K 0.03% 323